Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Recruiting2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting225%
withdrawn225%
completed450%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8